Biblio

Export 17 results:
Author Title [ Type(Desc)] Year
Filters: Keyword is Heterozygote  [Clear All Filters]
Journal Article
L. Wu, Liu, J., Feng, X., Dong, J., Qin, W., Liu, Y., Wang, J., Lu, J., Chen, K., Wang, Y., and Jia, J., 11C-CFT-PET in Presymptomatic FTDP-17: A Potential Biomarker Predicting Onset., J Alzheimers Dis, vol. 61, no. 2, pp. 613-618, 2018.
J. - Y. Liu, Ma, L. - Z., Wang, J., Cui, X. - J., Sheng, Z. - H., Fu, Y., Li, M., Ou, Y. - N., Yu, J. - T., Tan, L., and Lian, Y., Age-Related Association Between APOE ɛ4 and Cognitive Progression in de novo Parkinson's Disease., J Alzheimers Dis, vol. 91, no. 3, pp. 1121-1132, 2023.
C. Ferrari, Lombardi, G., Polito, C., Lucidi, G., Bagnoli, S., Piaceri, I., Nacmias, B., Berti, V., Rizzuto, D., Fratiglioni, L., and Sorbi, S., Alzheimer's Disease Progression: Factors Influencing Cognitive Decline., J Alzheimers Dis, vol. 61, no. 2, pp. 785-791, 2018.
J. L. Del-Aguila, Fernández, M. Victoria, Schindler, S., Ibanez, L., Deming, Y., Ma, S., Saef, B., Black, K., Budde, J., Norton, J., Chasse, R., Harari, O., Goate, A., Xiong, C., Morris, J. C., and Cruchaga, C., Assessment of the Genetic Architecture of Alzheimer's Disease Risk in Rate of Memory Decline., J Alzheimers Dis, vol. 62, no. 2, pp. 745-756, 2018.
G. Novak, Fox, N., Clegg, S., Nielsen, C., Einstein, S., Lu, Y., Tudor, I. Cristina, Gregg, K., Di, J., Collins, P., Wyman, B. T., Yuen, E., Grundman, M., H Brashear, R., and Liu, E., Changes in Brain Volume with Bapineuzumab in Mild to Moderate Alzheimer's Disease., J Alzheimers Dis, vol. 49, no. 4, pp. 1123-34, 2016.
X. Luo, Qiu, T., Xu, X., Huang, P., Gu, Q., Shen, Z., Yu, X., Jia, Y. L., Guan, X., Song, R., and Zhang, M., Decreased Inter-Hemispheric Functional Connectivity in Cognitively Intact Elderly APOE ɛ4 Carriers: A Preliminary Study., J Alzheimers Dis, vol. 50, no. 4, pp. 1137-48, 2016.
C. Alexander, Zeithamova, D., Hsiung, G. - Y. R., Mackenzie, I. R., and Jacova, C., Decreased Prefrontal Activation during Matrix Reasoning in Predementia Progranulin Mutation Carriers., J Alzheimers Dis, vol. 62, no. 2, pp. 583-589, 2018.
S. Kim, Nho, K., Ramanan, V. K., Lai, D., Foroud, T. M., Lane, K., Murrell, J. R., Gao, S., Hall, K. S., Unverzagt, F. W., Baiyewu, O., Ogunniyi, A., Gureje, O., Kling, M. A., P Doraiswamy, M., Kaddurah-Daouk, R., Hendrie, H. C., and Saykin, A. J., Genetic Influences on Plasma Homocysteine Levels in African Americans and Yoruba Nigerians., J Alzheimers Dis, vol. 49, no. 4, pp. 991-1003, 2016.
K. Konishi, Joober, R., Poirier, J., MacDonald, K., Chakravarty, M., Patel, R., Breitner, J., and Bohbot, V. D., Healthy versus Entorhinal Cortical Atrophy Identification in Asymptomatic APOE4 Carriers at Risk for Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 4, pp. 1493-1507, 2018.
J. Kim, Park, S., Yoo, H., Jang, H., Kim, Y., Kim, K. Woon, Jang, Y. Kyoung, San Lee, J., Kim, S. Tae, Kim, S., Lee, J. Min, Ki, C. - S., Na, D. L., Seo, S. Won, and Kim, H. Jin, The Impact of APOE ɛ4 in Alzheimer's Disease Differs According to Age., J Alzheimers Dis, vol. 61, no. 4, pp. 1377-1385, 2018.
C. M. Burns, Kaszniak, A. W., Chen, K., Lee, W., Bandy, D. J., Caselli, R. J., and Reiman, E. M., Longitudinal Changes in Serum Glucose Levels are Associated with Metabolic Changes in Alzheimer's Disease Related Brain Regions., J Alzheimers Dis, vol. 62, no. 2, pp. 833-840, 2018.
K. Katisko, Haapasalo, A., Koivisto, A., Krüger, J., Hartikainen, P., Korhonen, V., Helisalmi, S., Herukka, S. - K., Remes, A. M., and Solje, E., Low Prevalence of Cancer in Patients with Frontotemporal Lobar Degeneration., J Alzheimers Dis, vol. 62, no. 2, pp. 789-794, 2018.
S. Sapkota and Dixon, R. A., A Network of Genetic Effects on Non-Demented Cognitive Aging: Alzheimer's Genetic Risk (CLU + CR1 + PICALM) Intensifies Cognitive Aging Genetic Risk (COMT + BDNF) Selectively for APOEɛ4 Carriers., J Alzheimers Dis, vol. 62, no. 2, pp. 887-900, 2018.
S. Patel, Wei, J., Shi, Z., Rifkin, A. S., S Zheng, L., Gelfman, E., Duggan, D., Helfand, B. T., Hulick, P. J., and Xu, J., Refining Risk for Alzheimer's Disease Among Heterozygous APOEɛ4 Carriers., J Alzheimers Dis, vol. 94, no. 2, pp. 483-489, 2023.
M. D. Zwan, Villemagne, V. L., Doré, V., Buckley, R., Bourgeat, P., Veljanoski, R., Salvado, O., Williams, R., Margison, L., Rembach, A., S Macaulay, L., Martins, R., Ames, D., van der Flier, W. M., Ellis, K. A., Scheltens, P., Masters, C. L., and Rowe, C. C., Subjective Memory Complaints in APOEɛ4 Carriers are Associated with High Amyloid-β Burden., J Alzheimers Dis, vol. 49, no. 4, pp. 1115-22, 2016.
R. Guerreiro, Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J. S. K., Younkin, S., Hazrati, L., Collinge, J., Pocock, J., Lashley, T., Williams, J., Lambert, J. - C., Amouyel, P., Goate, A., Rademakers, R., Morgan, K., Powell, J., St George-Hyslop, P., Singleton, A., and Hardy, J., TREM2 variants in Alzheimer's disease., N Engl J Med, vol. 368, no. 2, pp. 117-27, 2013.
R. Sánchez-Valle, Monté, G. C., Sala-Llonch, R., Bosch, B., Fortea, J., Lladó, A., Antonell, A., Balasa, M., Bargalló, N., and Molinuevo, J. Luis, White Matter Abnormalities Track Disease Progression in PSEN1 Autosomal Dominant Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 3, pp. 827-35, 2016.